HCM
EW icon

Howard Capital Management’s Edwards Lifesciences EW Stock Holding History

Howard Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
+3,367
New +$282K ﹤0.01% 373
2026
Q1 		– Sell
-4,158
Closed -$354K – 364
2025
Q4 		$354K Buy
4,158
+22
+0.5% +$1.8K ﹤0.01% 351
2025
Q3 		$322K Buy
4,136
+132
+3% +$10.3K ﹤0.01% 357
2025
Q2 		$313K Buy
4,004
+532
+15% +$39.7K ﹤0.01% 348
2025
Q1 		$252K Sell
3,472
-533
-13% -$38.1K 0.01% 349
2024
Q4 		$296K Buy
4,005
+207
+5% +$14.5K ﹤0.01% 353
2024
Q3 		$251K Buy
+3,798
New +$276K ﹤0.01% 349

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Howard Capital Management's EW Position: Q2 2026 in Review

Howard Capital Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 3,367 shares worth $305K. The stake represents ﹤0.01% of the portfolio and ranks #373 among its holdings. This is a return to the name: Howard Capital Management previously reported a position in EW as recently as Q4 2025.

Howard Capital Management first reported a position in EW in Q3 2024 and has held it in 7 quarters since. The position peaked at $354K in Q4 2025. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Howard Capital Management held 3,367 shares of Edwards Lifesciences worth $305K as of Q2 2026.
  • Edwards Lifesciences was a new Howard Capital Management position in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Howard Capital Management's portfolio in Q2 2026, its #373 holding.
  • Howard Capital Management first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 7 quarters since.
  • Howard Capital Management's Edwards Lifesciences position peaked at $354K in Q4 2025.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.